NL-OMON25748Other不适用
A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700
Annovation Biopharma, University Medical Center Groningen (UMCG)0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 48
研究概览
简要总结
one
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy, adult, men and women, 18-45 years of age, inclusive.
- •2.Continuous non-smoker who has not used nicotine-containing products for at least 6 months prior to the first dose.
排除标准
- •1. History or presence of significant cardiovascular disease, or cardiovascular disease risk factors, hyperlipidemia, coronary artery disease, or any known genetic pre disposition to cardiac arrhythmia (including long QT syndrome.).
- •2.History or presence of significant pulmonary, hepatic, renal, hematological, gastrointestinal, endocrine, immunologic, dermatologic, neurological (inclusive of any seizure disorder), or psychiatric disease.
研究者
相似试验
已完成
不适用
A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700anesthesiaNL-OMON41980Annovation Biopharma, Inc. (a wholly owned subsidiary of The Medicines Company, Inc.)72
Unknown
不适用
A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus DoseNL-OMON27439Annovation Biopharma(University Medical Center Groningen)60
已完成
1 期
A Phase 1, Single-Center, Randomized, Placebo-Controlled, Ascending Single-Dose Study of the Pharmacokinetics, Safety, and Tolerability of Oral XG005 in Healthy VolunteersChronic PainACTRN12617001330336Xgene Pharmaceutical Inc.50
已完成
1 期
A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy AdultsHealthy Volunteers - Male and FemaleNCT06649942Kaken Pharmaceutical40
已完成
1 期
A phase 1, randomized, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetic profiles of OLX10010 in healthy subjects compared to placeboISRCTN64317949OliX Pharmaceuticals, Inc.48